Back
North American Construction Group Vs. Aligos Therapeutics Industry Stock Comparison
Buy
79
NOA.TO
North American Construction Group
Last Price:
29.91
Seasonality Move:
11.88%
Buy
75
ALGS
Aligos Therapeutics
Last Price:
33.60
Seasonality Move:
10.65%
Buy
79
North American Construction Group (NOA.TO)
is a Buy
Is North American Construction Group a Buy, Sell or Hold?
- The current North American Construction Group [NOA.TO] share price is $29.76. The Score for NOA.TO is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- NOA.TO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NOA.TO Stock Price Chart
What is North American Construction Group's stock price today?
-
The North American Construction Group share price today is $29.76
The current trend is moderately bullish and NOA.TO is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $34.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
NOA.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.74 | Buy |
Relative Strength Index (14 RSI): | 66.16 | Buy |
Chaikin Money Flow: | 5056 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.6 - 29.14) | Buy |
Bollinger Bands (100): | (24.53 - 27.93) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.71 | Buy |
Relative Strength Index (14 RSI): | 85.17 | Buy |
Chaikin Money Flow: | 491004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.08 - 27.66) | Buy |
Bollinger Bands (100): | (7.67 - 19.61) | Buy |
NOA.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.15 | Buy |
20-day SMA: | 28.35 | Buy |
50-day SMA: | 26.87 | Buy |
200-day SMA: | 27.7 | Buy |
8-day EMA: | 29.23 | Buy |
20-day EMA: | 28.51 | Buy |
50-day EMA: | 27.44 | Buy |
200-day EMA: | 25.99 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.48 | Buy |
20-day SMA: | 23.64 | Buy |
50-day SMA: | 14.76 | Buy |
200-day SMA: | 15.86 | Buy |
8-day EMA: | 28.77 | Buy |
20-day EMA: | 23.99 | Buy |
50-day EMA: | 18.16 | Buy |
200-day EMA: | 16.13 | Buy |
North American Construction Group Earnings Growth & NOA.TO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.90 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
North American Construction Group Technical Analysis
Nov 28 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
28 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |